Granulocytic sarcoma is a form of extramedullary involvement of primitive myeloid cells. A 69-year-old male patient, with history of acute myeloid leukemia (AML) in remission state for 4 years, presented numbness, radiating pain and progressive motor weakness in left leg. MRI showed perineural thickening of the left sciatic nerve with increased signal intensity on fat-saturated T2-weighted image. The patient underwent surgical excision and the pathology was confirmed as granulocytic sarcoma. Its involvement of the peripheral nerve is extremely rare and also unusual to be the only evidence of AML relapse. In this case, we figured out the MRI feature of granulocytic sarcoma involving sciatic nerve, emerged as a sole manifestation of AML relapse.
INTRODUCTION
Granulocytic sarcoma, also called myeloid sarcoma or chloroma, is a localized tumorous lesion of primitive myeloid cells at extramedullary site (1) . Granulocytic sarcoma can occur in any tissue, but the most common locations are soft tissues, bone, peritoneum, lymph nodes, and gastrointestinal system. Other sites that are presented in literatures are the genitourinary system and central nervous system (CNS) including spinal nerve (2) . The involvement of the peripheral nerve is extremely rare and only a few cases were reported as relapsed acute myeloid leukemia (AML) with other con-Tel 82-2-3779-2037 Fax 82-2-783-5288 E-mail jmpark@catholic.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 
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CASE REPORT
A 69-year-old man presented with numbness and radiating pain on his left leg, mainly in left lower leg and left sole. Also the posterior muscles of left lower leg were gradually atrophied. His symptom had been aggravated for 6 months. He had a history of 4 years of chemotherapy for AML, which had been in complete remission state. On physical examination, (Fig.   1A , B). The sciatic nerve was surrounded by thickened peripheral nerve sheath which shows markedly high signal intensity on fat-saturated T2-weighted images and intermediate signal intensity on T1-weighted image (Fig. 1A, B) . Also, prominent enhancement of peripheral nerve sheath was noted on gadolinium-enhanced axial T1-weighted MRI, but the sciatic nerve itself showed only mild and mottled enhancement (Fig. 1C) . On gadolinium-enhanced sagittal T1-weighted MRI, an about 19 cm length of fusiform enlargement of the sciatic nerve was observed along left distal femur level, with irregular peripheral nerve sheath thickening and enhancement was well demonstrated (Fig. 1D) . The patient underwent decompression with epineurectomy and nerve sheath partial excision. During the surgery, the pale brown colored, rubbery to hard sciatic nerve with diffuse enlargement was observed. After epineurectomy of thickened epineurium, the sciatic nerve was exposed and showed mild swollen state. The sciatic nerve resection was not performed considering nerve injury.
Microscopically, there was diffuse infiltration of atypical tumor cells around the nerve fibers and surrounding soft tissue (Fig. 1E) . The tumor cells were monotonously angulated or polygonal shaped with hyperchromatic round nuclei and prominent small nucleoli, and eosinophilic cytoplasm. The immunohistochemical staining showed negative for CD3 and CD20 (Ventana, CA, USA, prediluted), but diffuse positive for myeloperoxidase (Ventana, prediluted) (Fig. 1F) . The Leder stain for chloroacetate esterase was focally positive. Considering these staining patterns and patient's clinical history, the pathologic result was assumed as leukemic cells derived from the myeloid lineage and lymphoma could be excluded. Finally, the surgical specimens of sciatic and tibial nerve sheath, and perineural fat tissue were confirmed as granulocytic sarcoma.
After pathologic confirmation of granulocytic sarcoma, the patient underwent bone marrow biopsy but there was no evidence of systemic relapse of AML. The patient started chemotherapy including cytarabine and mitrone. However, he was lost to follow-up after firstcycle of the treatment.
DISCUSSION
Granulocytic sarcoma is a rare disease, presented as an isolated solid tumor composed of immature white blood cells called myeloblasts. It is an extramedullary manifestation of AML and can be a manifestation of relapse after successful treatment of AML. According to Novick et al. (3) , the prevalence of granulocytic sarcoma of any organ is about 3.1-9.1% of AML patients. Also, the frequency of extramedullary relapse after successful treatment is about 5-12% of all patients with acute leukemia (4). Vulnerable sites prone to recurrent disease include the testes, CNS, and the eye, followed by breast, paranasal sinuses and gastrointestinal tract (5) . Since granulocytic sarcoma rarely presents as the only manifestation of initial expression or relapse of AML, it is very difficult to suspect granulocytic sarcoma as the first diagnosis.
In case of the peripheral nervous system (PNS), extramedullary relapse seems to be much less common than the CNS (6) . Granulocytic sarcoma in the PNS usually presents as mono-and polyneuropathies. It has been rarely reported in the literature and, due to a small number of patients, there are no definite imaging findings for this group of patients in consensus (6) . Two case reports about sciatic nerve involvement and one case report about median nerve involvement were previously presented (7-9). They were occurred in relapsed AML, but there was other accompanied systemic involvement of AML.
In these reports, image findings were demonstrated as either soft tissue mass-forming type, which is also generally shown in other organs, or perineural involvement type.
Among these case reports, according to Stillman et al. (7), the lesion is shown as bulgingout mass-forming type, compressing sciatic nerve. In the general cases of mass-forming type involving typical vulnerable sites, it is appeared as discrete solid mass invading and occupying the space of the organ, with isointense to slightly hyperintense signal intensity on T1 and T2-weighted images of MRI and variable enhancement (10) . According to pathologic inspection, both perineural involving type of granulocytic sarcoma and inflammatory neuritis can show mature or immature lymphocyte infiltration along the nerve and nerve sheath. Therefore, they might share similar imaging findings such as swelling of nerve and neural sheath on MRI image, and this may lead the radiologist to be confused between these two differential diagnoses.
Although there are only a few sporadic case reports about PNS involvement of granulocytic sarcoma, the reports about CNS, or spinal cord involvement, are better organized.
According to Seok et al. (2), when we look at the granulocytic sarcoma of spinal nerve, the lesion usually appears at the epidural space of the central spinal canal, epidural re-gion along the nerve root course, thickening of the nerve itself, or a prevertebral lesion.
In cases of nerve itself involvement, enlarged nerve without epidural mass is presented on MRI. As compared with our case, which is involving PNS, it is similar that it appears as a nerve enlargement. Thus, through this study about spinal nerve involvement of granulocytic sarcoma, we can confirm the various nerve involvement of granulocytic sarcoma, and one of them shows a finding similar to our case.
In summary, we report a rare case of granulocytic sarcoma involving sciatic nerve, which was the only evidence of relapse in the patient with remission state of AML. Radiologists should be aware of the possibility of granulocytic sarcoma as a differential diagnosis when the patient has the history of AML and the image finding shows atypical mass or severe form of neuritis.
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